424 related articles for article (PubMed ID: 18458436)
1. Assessment of angiogenic properties of biomaterials using the chicken embryo chorioallantoic membrane assay.
Azzarello J; Ihnat MA; Kropp BP; Warnke LA; Lin HK
Biomed Mater; 2007 Jun; 2(2):55-61. PubMed ID: 18458436
[TBL] [Abstract][Full Text] [Related]
2. Nerve growth factor (NGF) promotes angiogenesis in the quail chorioallantoic membrane.
Lazarovici P; Gazit A; Staniszewska I; Marcinkiewicz C; Lelkes PI
Endothelium; 2006; 13(1):51-9. PubMed ID: 16885067
[TBL] [Abstract][Full Text] [Related]
3. Enhanced angiogenesis of modified porcine small intestinal submucosa with hyaluronic acid-poly(lactide-co-glycolide) nanoparticles: from fabrication to preclinical validation.
Mondalek FG; Ashley RA; Roth CC; Kibar Y; Shakir N; Ihnat MA; Fung KM; Grady BP; Kropp BP; Lin HK
J Biomed Mater Res A; 2010 Sep; 94(3):712-9. PubMed ID: 20213816
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of angiogenic activities of hyaluronan oligosaccharides of defined minimum size.
Cui X; Xu H; Zhou S; Zhao T; Liu A; Guo X; Tang W; Wang F
Life Sci; 2009 Oct; 85(15-16):573-7. PubMed ID: 19720068
[TBL] [Abstract][Full Text] [Related]
5. Adipose precursor cells (preadipocytes) induce formation of new vessels in fibrin glue on the newly developed cylinder chorioallantoic membrane model (CAM).
Borges J; Torío-Padrón N; Momeni A; Mueller MC; Tegtmeier FT; Stark BG
Minim Invasive Ther Allied Technol; 2006; 15(4):246-52. PubMed ID: 16966139
[TBL] [Abstract][Full Text] [Related]
6. Tetraiodothyroacetic acid, a small molecule integrin ligand, blocks angiogenesis induced by vascular endothelial growth factor and basic fibroblast growth factor.
Mousa SA; Bergh JJ; Dier E; Rebbaa A; O'Connor LJ; Yalcin M; Aljada A; Dyskin E; Davis FB; Lin HY; Davis PJ
Angiogenesis; 2008; 11(2):183-90. PubMed ID: 18080776
[TBL] [Abstract][Full Text] [Related]
7. In vivo evaluation of the angiogenic effects of the multiblock copolymer PDC using the hen's egg chorioallantoic membrane test.
Hiebl B; Mrowietz C; Goers J; Bahramsoltani M; Plendl J; Kratz K; Lendlein A; Jung F
Clin Hemorheol Microcirc; 2010; 46(2-3):233-8. PubMed ID: 21135499
[TBL] [Abstract][Full Text] [Related]
8. Quantification of in vitro and in vivo angiogenesis stimulated by ovine forestomach matrix biomaterial.
Irvine SM; Cayzer J; Todd EM; Lun S; Floden EW; Negron L; Fisher JN; Dempsey SG; Alexander A; Hill MC; O'Rouke A; Gunningham SP; Knight C; Davis PF; Ward BR; May BC
Biomaterials; 2011 Sep; 32(27):6351-61. PubMed ID: 21665268
[TBL] [Abstract][Full Text] [Related]
9. The effect of cross-linking of collagen matrices on their angiogenic capability.
Yao C; Markowicz M; Pallua N; Noah EM; Steffens G
Biomaterials; 2008 Jan; 29(1):66-74. PubMed ID: 17935778
[TBL] [Abstract][Full Text] [Related]
10. A comparative study on the effects of tumor necrosis factor-alpha (TNF-alpha), human angiogenic factor (h-AF) and basic fibroblast growth factor (bFGF) on the chorioallantoic membrane of the chick embryo.
Olivo M; Bhardwaj R; Schulze-Osthoff K; Sorg C; Jacob HJ; Flamme I
Anat Rec; 1992 Sep; 234(1):105-15. PubMed ID: 1384395
[TBL] [Abstract][Full Text] [Related]
11. Pro-angiogenic properties of orosomucoid (ORM).
Irmak S; Oliveira-Ferrer L; Singer BB; Ergün S; Tilki D
Exp Cell Res; 2009 Nov; 315(18):3201-9. PubMed ID: 19651122
[TBL] [Abstract][Full Text] [Related]
12. A VEGF165-induced phenotypic switch from increased vessel density to increased vessel diameter and increased endothelial NOS activity.
Parsons-Wingerter P; Chandrasekharan UM; McKay TL; Radhakrishnan K; DiCorleto PE; Albarran B; Farr AG
Microvasc Res; 2006 Nov; 72(3):91-100. PubMed ID: 16872639
[TBL] [Abstract][Full Text] [Related]
13. Selective inhibition of angiogenesis in small blood vessels and decrease in vessel diameter throughout the vascular tree by triamcinolone acetonide.
McKay TL; Gedeon DJ; Vickerman MB; Hylton AG; Ribita D; Olar HH; Kaiser PK; Parsons-Wingerter P
Invest Ophthalmol Vis Sci; 2008 Mar; 49(3):1184-90. PubMed ID: 18326748
[TBL] [Abstract][Full Text] [Related]
14. PPAR gamma ligands, rosiglitazone and pioglitazone, inhibit bFGF- and VEGF-mediated angiogenesis.
Aljada A; O'Connor L; Fu YY; Mousa SA
Angiogenesis; 2008; 11(4):361-7. PubMed ID: 18810647
[TBL] [Abstract][Full Text] [Related]
15. The gelatin sponge-chorioallantoic membrane assay.
Ribatti D; Nico B; Vacca A; Presta M
Nat Protoc; 2006; 1(1):85-91. PubMed ID: 17406216
[TBL] [Abstract][Full Text] [Related]
16. An alternative in vivo system for testing angiogenic potential of human neuroblastoma cells.
Mangieri D; Nico B; Coluccia AM; Vacca A; Ponzoni M; Ribatti D
Cancer Lett; 2009 May; 277(2):199-204. PubMed ID: 19150583
[TBL] [Abstract][Full Text] [Related]
17. Ex ova chick chorioallantoic membrane as a novel model for evaluation of tissue responses to biomaterials and implants.
Klueh U; Dorsky DI; Moussy F; Kreutzer DL
J Biomed Mater Res A; 2003 Dec; 67(3):838-43. PubMed ID: 14613232
[TBL] [Abstract][Full Text] [Related]
18. The use of the chick embryo CAM assay in the study of angiogenic activiy of biomaterials.
Ribatti D; Annese T; Tamma R
Microvasc Res; 2020 Sep; 131():104026. PubMed ID: 32505611
[TBL] [Abstract][Full Text] [Related]
19. Viral serpin, Serp-1, inhibits endogenous angiogenesis in the chicken chorioallantoic membrane model.
Richardson M; Liu L; Dunphy L; Wong D; Sun Y; Viswanathan K; Singh G; Lucas A
Cardiovasc Pathol; 2007; 16(4):191-202. PubMed ID: 17637427
[TBL] [Abstract][Full Text] [Related]
20. Angiogenic response induced by acellular aortic matrix in vivo.
Conconi MT; Nico B; Mangieri D; Tommasini M; di Liddo R; Parnigotto PP; Nussdorfer GG; Ribatti D
Anat Rec A Discov Mol Cell Evol Biol; 2004 Dec; 281(2):1303-7. PubMed ID: 15532047
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
